Stelios Therapeutics is a startup focused on creating innovative gene therapies using AAV technology for rare genetic heart conditions. The company was established by a team of distinguished researchers and scientists with a strong background in gene therapy drug development, building upon research conducted at the University of California San Diego (UCSD).